{"schema_version":"secwatch.filing_event.v1","accession":"0001528287-23-000028","form_type":"8-K","ticker":"NPCE","cik":"0001528287","company_name":"NeuroPace Inc","filed_at":"2023-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.266411+00:00","generated_at":"2026-06-14T02:55:07.335469+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"NeuroPace stockholders elect two Class II directors, ratify PwC as auditor at 2023 annual meeting","bullets":["Elected Lisa Andrade (8,506,611 for, 432,292 withhold) and Joseph Lacob (8,475,094 for, 463,809 withhold) as Class II directors until 2026.","Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2023: 16,456,369 for, 9,012 against, 11,989 abstain.","Broker non-votes of 7,538,467 on director election; no broker non-votes on auditor ratification.","No other matters were submitted for stockholder action at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001528287-23-000028","json":"https://secwatch.observer/filing/0001528287-23-000028.json","markdown":"https://secwatch.observer/filing/0001528287-23-000028.md","text":"https://secwatch.observer/filing/0001528287-23-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1528287/000152828723000028/0001528287-23-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1528287/000152828723000028/npce-20230607.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T02:55:07.335469+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"853a5e6c4b35abcb74d96f41bdcee6262f769564","claim":"NeuroPace Inc shareholders approved Election of Class II directors at the 2023-06-07 meeting.","evidence_excerpt":"NeuroPace’s stockholders elected each of the following Class II director nominees to hold office until NeuroPace’s 2026 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal. The results of the vote were: Nominee For Withhold Broker Non-Votes Lisa Andrade 8,506,611 432,292 7,538,467 Joseph Lacob 8,475,094 463,809 7,538,467","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1528287/000152828723000028/0001528287-23-000028-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"},{"claim_id":"c1eba4486e6fc5ffed484431e7c579436e96d997","claim":"NeuroPace Inc shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2023-06-07 meeting.","evidence_excerpt":"NeuroPace’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as NeuroPace’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The results of the vote were: For Against Abstain Broker Non-Votes 16,456,369 9,012 11,989 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1528287/000152828723000028/0001528287-23-000028-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}